Groupe Batteur Laboratoires Gilbert
⚠️ High Risk
FEI: 3004512844 • Herouville St Clair • FRANCE
FEI Number
3004512844
Location
Herouville St Clair
Country
FRANCEAddress
Avenue De Dubna, , Herouville St Clair, , France
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
LACK NOTIF
Adulterated, 801(a)(3), lack of documentation establishing that the infant formula meets all notification conditions required by 412(c) or 412(d), Prohibited Act, Section 301(s).
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/12/2025 | 40PYY01MILK BASE INFANT FORMULA PRODUCT (0-12 MONTHS), POWDER FORMULA | Division of Southeast Imports (DSEI) | |
| 4/25/2023 | 66VIQ99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 8/17/2022 | 65FBK06WATER, PURIFIED (EYEWASH) | 118NOT LISTED | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is Groupe Batteur Laboratoires Gilbert's FDA import refusal history?
Groupe Batteur Laboratoires Gilbert (FEI: 3004512844) has 3 FDA import refusal record(s) in our database, spanning from 8/17/2022 to 11/12/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Groupe Batteur Laboratoires Gilbert's FEI number is 3004512844.
What types of violations has Groupe Batteur Laboratoires Gilbert received?
Groupe Batteur Laboratoires Gilbert has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Groupe Batteur Laboratoires Gilbert come from?
All FDA import refusal data for Groupe Batteur Laboratoires Gilbert is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.